Skip to main content

7 Result(s)

within R-O Casasnovas Remove this filter

and

  1. No Access

    Article

    Phase 1b study of lenalidomide in combination with rituximab-CHOP (R2-CHOP) in patients with B-cell lymphoma

    H Tilly, F Morschhauser, G Salles, R-O Casasnovas, P Feugier, T J Molina… in Leukemia (2013)

  2. No Access

    Chapter

    Lymphome de Hodgkin : traitement de première ligne des stades avancés

    Le paysage de la prise en charge des lymphomes de Hodgkin (LH) avancés s’est sensiblement modifié durant les 10 dernières années. L’introduction de nouveaux schémas thérapeutiques plus intenses permet d’amélio...

    R. O. Casasnovas in Actualités thérapeutiques dans les lymphomes (2013)

  3. No Access

    Chapter

    Maladie de Hodgkin

    Le lymphome de Hodgkin (LH)reste une entité distincte au sein des lymphomes malins. C’ est une affection dont le diagnostic repose sur un critère uniquement morphologique: la présence de cellules de Sternberg ...

    P. M. Carli, A. Monnereau, R.O. Casasnovas… in Survie des patients atteints de cancer en … (2007)

  4. No Access

    Chapter

    Lymphomes malins non hodgkiniens

    Les lymphomes malins non hodgkiniens (LMNH)sont des proliférations malignes du tissu lym- phoïde dont le diagnostic résulte toujours de l’examen d’une biopsie tissulaire.Celle-ci permet de les distinguer du ly...

    P. M. Carli, A. Monnereau, R. O. Casasnovas… in Survie des patients atteints de cancer en … (2007)

  5. No Access

    Article

    Immunological classification of acute myeloblastic leukemias: relevance to patient outcome

    Immunophenoty** is a major tool to assign acute leukemia blast cells to the myeloid lineage. However, because of the large heterogeneity of myeloid-related lineages, no clinically relevant immunological clas...

    R O Casasnovas, F K Slimane, R Garand, G C Faure, L Campos, V Deneys, M Bernier… in Leukemia (2003)

  6. No Access

    Article

    Sequential chemotherapy by CHOP and DHAP regimens followed by high-dose therapy with stem cell transplantation induces a high rate of complete response and improves event-free survival in mantle cell lymphoma: a prospective study

    Mantle cell lymphoma (MCL) is a distinct clinico-pathological entity with a poor prognosis. We have conducted a prospective study in patients with MCL to evaluate a therapeutic strategy in which CHOP polychemo...

    F Lefrère, A Delmer, F Suzan, V Levy, C Belanger, M Djabarri, B Arnulf, G Damaj… in Leukemia (2002)

  7. No Access

    Article

    Phase I study of cinchonine, a multidrug resistance reversing agent, combined with the CHVP regimen in relapsed and refractory lymphoproliferative syndromes

    Overexpression of P-glycoprotein (P-gp) in cancer cells reduces intracellular accumulation of various anticancer drugs including anthracyclines and vinca alkaloids. This multidrug resistance (MDR) phenotype ca...

    E Solary, L Mannone, D Moreau, D Caillot, R-O Casasnovas, H Guy, M Grandjean… in Leukemia (2000)